He was looking to scare retails, so he could cover/buy. That's the worst of the human race, and karma will take care of it.
Right on, MGM. "Opportunity cost" is another cliche for 20-20 hindsight. In this sector, stick with the fundamentals, and IDRA has superior fundamentals across the board. It's no wonder they imposed a 5% investment limit on institutions. No one in their right mind would even consider such a thing, especially this industry, UNLESS they had absolute PURE GOLD. And that's exactly what Agrawal calls his 3rd-gen GSO. Let's see--- 3rd gen GSO, Gene-targeting 8400, Broad disease TLR 9200, Bakers, Fidelity, Goldman, JPM, Superstars of past biotech success stories. In 2017, we'll be looking at 4-5bill MC or 40-50/share easy, and it may start tomorrow, or it may start next week, or it may start next year. I don't care. I'm buying every share I can afford for the fundamental payday.
Beautiful. Northward we go with a superstar at the helm. What a hire by the Bakers. Absolutely brilliant pick and lure.
Should be a good pick and a catalyst. 10-1 odds they already have the person lined up with announcement soon. Quite a few news catalysts await long shareholders this year and beyond, with each one stronger than the last.
2015 will be the kickoff to a massive very long run for IDRA. Exciting times for sure.
HAHA...good find tursta. I'm sure Lou just expected a track to IDRA CEO. When the Bakers took the 2 BOD seats, they made very deliberate moves: 1. Kept Sudhir onboard and happy as pie focusing 100% on his GSO babe. 2. Handpicked a stud in Milano even allowing him to work from his home in Philly.3. Persuaded Goldman Sachs and JPM to buy in large (not an easy feat at all, esp in biotech)....there is one common theme here----all of these heavyhitters have seen something that blows their mind.
Of course, he's gotta execute. If he wanted Brenner, he would've made him an offer he couldn't refuse. You can bet they talked about it at length, and Milano has someone ready to go. We're talking about a very networked successful management team here, not to mention the Bakers, who probably know a superstar or 2 to replace him. Buy the fear, sell the euphoria.
He took COO job, nice opportunity for the man. Doesn't mean he thinks any less of IDRA as he owns $1 million worth. Hey, I just changed jobs, too, but I kept my IDRA.
"If we observe sufficient tolerability and a therapeutic effect in either or both of our Phase 1/2 clinical trials, we plan to meet with regulatory authorities to discuss an accelerated clinical development and regulatory path for the applicable program.".......so, yes, news can come out sooner since it's open-label. Full data EOY. Surprise sooner.
Not that I care about the fluctuations short-term because I know this is heading 40+ 3-5 years tops. BUT....Friday was a buying opportunity. 6% down on a stock loaded with promise across the board, is a day to buy....even if you're a trader. We are, AT THE VERY LATEST, 9 months away from WM's single-gene target results. And that translates to a s#$tload of B-cell lymphomas, Burkitt's, and on and on...I personally believe we'll be getting some WM news sooner as well as 2055 announcement as well as 9200 Lupus any day now....GS and JPM are selective. I'm more excited by the day with these guys. Remember what Agrawal said? Our GSO has "Picture perfect results"....now take a look at ISIS old gen GSO. They'll have to look fast to catch IDRA's license plate in a couple years. Real deal here. Someday, instead of people saying, "This is going to be another PCYC", they are going to be saying, "This is going to be another IDRA"....hold on to your shares tightly.
Sentiment: Strong Buy
Ha dude, I purchased more at exact same price as you today when I interpreted what was going on as major repositioning for up move. Good going, Dude.